Clinical expression in Pfeiffer syndrome type 2 and 3: surveillance in Japan

Hiroshi Koga1, Naohiro Suga, Takato Nakamoto

  • 1Department of Pediatrics, National Hospital Organization Beppu Medical Center, Oita, Japan. sakuraliberty@beppu2.hosp.go.jp

Insights

Pfeiffer syndrome (PS) is a rare craniosynostosis. Elbow ankylosis and sacrococcygeal defects are key early diagnostic signs in newborns with PS, aiding prompt medical intervention.

Area of Science:

  • Medical Genetics
  • Pediatric Surgery
  • Clinical Dysmorphology

Background:

  • Pfeiffer syndrome (PS) is a rare craniosynostosis syndrome with significant morbidity.
  • Early diagnosis of PS is challenging due to low awareness and rarity.
  • Severe PS cases necessitate immediate neonatal intensive care.

Purpose of the Study:

  • To identify key phenotypic features for early diagnosis of Pfeiffer syndrome (PS) types 2 and 3.
  • To improve diagnostic accuracy and timeliness in newborns presenting with craniosynostosis.

Main Methods:

  • Retrospective review of 23 Japanese patients with Pfeiffer syndrome types 2 or 3 (1980-2011).
  • Extraction and analysis of clinical and genetic data from medical records.
  • Identification of characteristic phenotypic manifestations and their prevalence.

Main Results:

  • All 23 patients exhibited craniosynostosis, midface hypoplasia, proptosis, broad thumbs, and wide great toes.
  • FGFR2 mutations were confirmed in 8/8 genetically analyzed patients.
  • Elbow ankylosis (70%) and sacrococcygeal defects (30%) were significant additional findings.

Conclusions:

  • Elbow ankylosis and sacrococcygeal defects are highly suggestive phenotypic markers for PS in neonates.
  • Recognizing these distinctive features can facilitate earlier diagnosis and management of Pfeiffer syndrome.
  • Despite characteristic symptoms, a significant mortality rate (22%) was observed before one year of age.

Related Concept Videos

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...